CST6 and breast carcinoma: Work by others showed methylation of CST6 to be associated with worse patient prognosis in breast cancer (Kioulafa et al., 2009), whereas the encoded protein (cystatin M) inhibited breast cancer cell proliferation, motility and metastasis (Zhang et al., 2004).